Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Biotechnol Adv. 2018 Feb 28;36(4):935–953. doi: 10.1016/j.biotechadv.2018.02.014

Figure 3.

Figure 3

Estimated chronological depiction of major points in the development of D-series resolvin mediators controlling inflammation and promoting resolution of inflammation. Timeline displays the estimated progression of the fish oil-enriched diet to the development of drugs for the treatment of hyperlipidemia to the advancement of D-series mediators from DHA.